Unilateral Multiple Tuberous Xanthomas Mimicking Multiple Lipomatosis in Type Iia Hypercholesterolemia- a Case Report with Review
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Genetic Determinants Underlying Rare Diseases Identified Using Next-Generation Sequencing Technologies
Western University Scholarship@Western Electronic Thesis and Dissertation Repository 8-2-2018 1:30 PM Genetic determinants underlying rare diseases identified using next-generation sequencing technologies Rosettia Ho The University of Western Ontario Supervisor Hegele, Robert A. The University of Western Ontario Graduate Program in Biochemistry A thesis submitted in partial fulfillment of the equirr ements for the degree in Master of Science © Rosettia Ho 2018 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Medical Genetics Commons Recommended Citation Ho, Rosettia, "Genetic determinants underlying rare diseases identified using next-generation sequencing technologies" (2018). Electronic Thesis and Dissertation Repository. 5497. https://ir.lib.uwo.ca/etd/5497 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. Abstract Rare disorders affect less than one in 2000 individuals, placing a huge burden on individuals, families and the health care system. Gene discovery is the starting point in understanding the molecular mechanisms underlying these diseases. The advent of next- generation sequencing has accelerated discovery of disease-causing genetic variants and is showing numerous benefits for research and medicine. I describe the application of next-generation sequencing, namely LipidSeq™ ‒ a targeted resequencing panel for the identification of dyslipidemia-associated variants ‒ and whole-exome sequencing, to identify genetic determinants of several rare diseases. Utilization of next-generation sequencing plus associated bioinformatics led to the discovery of disease-associated variants for 71 patients with lipodystrophy, two with early-onset obesity, and families with brachydactyly, cerebral atrophy, microcephaly-ichthyosis, and widow’s peak syndrome. -
'Sitosterolemia—10 Years Observation in Two Sisters'
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2019 Sitosterolemia—10 years observation in two sisters Veit, Lara ; Allegri Machado, Gabriella ; Bürer, Céline ; Speer, Oliver ; Häberle, Johannes Abstract: Familial hypercholesterolemia due to heterozygous low‐density lipoprotein‐receptor mutations is a common inborn errors of metabolism. Secondary hypercholesterolemia due to a defect in phytosterol metabolism is far less common and may escape diagnosis during the work‐up of patients with dyslipi- demias. Here we report on two sisters with the rare, autosomal recessive condition, sitosterolemia. This disease is caused by mutations in a defective adenosine triphosphate‐binding cassette sterol excretion transporter, leading to highly elevated plant sterol concentrations in tissues and to a wide range of symp- toms. After a delayed diagnosis, treatment with a diet low in plant lipids plus ezetimibe to block the absorption of sterols corrected most of the clinical and biochemical signs of the disease. We followed the two patients for over 10 years and report their initial presentation and long‐term response to treatment. DOI: https://doi.org/10.1002/jmd2.12038 Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-182906 Journal Article Accepted Version Originally published at: Veit, Lara; Allegri Machado, Gabriella; Bürer, Céline; Speer, Oliver; Häberle, Johannes (2019). Sitosterolemia— 10 years observation in -
A Case of Xanthoma Disseminatum Accentuating Over the Eyelids
Ann Dermatol Vol. 22, No. 3, 2010 DOI: 10.5021/ad.2010.22.3.353 CASE REPORT A Case of Xanthoma Disseminatum Accentuating over the Eyelids Jun Young Kim, M.D., Hong Dae Jung, M.D., Yoon Seok Choe, M.D., Weon Ju Lee, M.D., Seok-Jong Lee, M.D., Do Won Kim, M.D., Byung Soo Kim, M.D.1 Department of Dermatology, Kyungpook National University School of Medicine, Daegu, 1Department of Dermatology, Medical Research Institute, Pusan National University School of Medicine, Busan, Korea Xanthoma disseminatum (XD) is a rare, benign non-familial -Keywords- mucocutaneous disorder, which is a subset of non- Blinding, Field of vision, Xanthoma disseminatum, Xero- Langerhans cell histiocytosis. It is characterized by muco- phthalmia cutaneous xanthomas in a disseminated form typically involving the eyelids, trunk, face, and proximal extremities and occurs in flexures and folds such as axillae and the groin. INTRODUCTION Mucosal involvement of the respiratory or gastrointestinal tracts may lead to hoarseness or intestinal obstruction from Xanthoma disseminatum (XD) is a rare, benign proli- a mechanical mass effect. This paper outlines the case of a ferative dermatologic disorder of unknown etiology1. It is 47-year-old female with progressive yellow-to-brown con- classified as a subset of cutaneous non-Langerhans cell fluent nodules and plaques of various sizes on her scalp, face, histiocytosis (NLCH). XD typically manifests as hundreds oral mucosa, neck, shoulder, axillary folds, and perianal of discrete papules and nodules, which are red-brown to area. Xanthomas accentuating over the eyelids and yellow in color1. They chiefly involve the face and trunk, eyelashes led to partial obstruction of her visual field and and occur in flexures and folds such as the axillae and interfered with blinking. -
Lipoprotein Lipase: a General Review Moacir Couto De Andrade Júnior1,2*
Review Article iMedPub Journals Insights in Enzyme Research 2018 www.imedpub.com Vol.2 No.1:3 ISSN 2573-4466 DOI: 10.21767/2573-4466.100013 Lipoprotein Lipase: A General Review Moacir Couto de Andrade Júnior1,2* 1Post-Graduation Department, Nilton Lins University, Manaus, Amazonas, Brazil 2Department of Food Technology, Instituto Nacional de Pesquisas da Amazônia (INPA), Manaus, Amazonas, Brazil *Corresponding author: MC Andrade Jr, Post-Graduation Department, Nilton Lins University, Manaus, Amazonas, Brazil, Tel: +55 (92) 3633-8028; E-mail: [email protected] Rec date: March 07, 2018; Acc date: April 10, 2018; Pub date: April 17, 2018 Copyright: © 2018 Andrade Jr MC. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Citation: Andrade Jr MC (2018) Lipoprotein Lipase: A General Review. Insights Enzyme Res Vol.2 No.1:3 Abstract Lipoprotein Lipase: Historical Hallmarks, Enzymatic Activity, Characterization, and Carbohydrates (e.g., glucose) and lipids (e.g., free fatty acids or FFAs) are the most important sources of energy Present Relevance in Human for most organisms, including humans. Lipoprotein lipase (LPL) is an extracellular enzyme (EC 3.1.1.34) that is Pathophysiology and Therapeutics essential in lipoprotein metabolism. LPL is a glycoprotein that is synthesized and secreted in several tissues (e.g., Macheboeuf, in 1929, first described chemical procedures adipose tissue, skeletal muscle, cardiac muscle, and for the isolation of a plasma protein fraction that was very rich macrophages). At the luminal surface of the vascular in lipids but readily soluble in water, such as a lipoprotein [1]. -
Difference Between Dyslipidemia and Hyperlipidemia Key Difference – Dyslipidemia Vs Hyperlipidemia
Difference Between Dyslipidemia and Hyperlipidemia www.differenebetween.com Key Difference – Dyslipidemia vs Hyperlipidemia Dyslipidemia and hyperlipidemia are two medical conditions that affect the lipid levels of the body. Any deviation of the lipid level of the body from the normal and clinically appropriate values is identified as dyslipidemia. Hyperlipidemia is a form of dyslipidemia where the lipid levels are abnormally elevated. The key difference between dyslipidemia and hyperlipidemia is that dyslipidemia refers to any abnormality in the lipid levels whereas hyperlipidemia refers to an abnormal elevation in the lipid level. What is Dyslipidemia? Any abnormality in the lipid levels of the body is identified as dyslipidemia. Different forms of dyslipidemia include Hyperlipidemia Hypolipidemia Lipid levels of the body are abnormally reduced in this condition. Severe protein energy malnutrition, severe malabsorption, and intestinal lymphangiectasia are the causes. Hypolipoproteinemia This disease is caused by genetic or acquired causes. The familial form of hypolipoproteinemia is asymptomatic and does not require treatments. But there are some other forms of this condition which are extremely severe. Genetic disorders associated with this condition are, Abeta lipoproteinemia Familial hypobetalipoproteinemia Chylomicron retention disease Lipodystrophy Lipomatosis Dyslipidemia in pregnancy What is Hyperlipidemia? Hyperlipidemia is a form of dyslipidemia that is characterized by abnormally elevated lipid levels. Primary Hyperlipidemia Primary hyperlipidemias are due to a primary defect in the lipid metabolism. Classification Disorders of VLDL and chylomicrons- hypertriglyceridemia alone The commonest cause of these disorders is the genetic defects in multiple genes. There is a modest increase in the VLDL level. Disorders of LDL- hypercholesterolemia alone There are several subgroups of this category Heterozygous Familial Hypercholesterolemia This is a fairly common autosomal dominant monogenic disorder. -
Unusual Variants of Non-Langerhans Cell Histiocytoses
REVIEWS Unusual variants of non-Langerhans cell histiocytoses Ruggero Caputo, MD,a Angelo Valerio Marzano, MD,a Emanuela Passoni, MD,a and Emilio Berti, MDb Milan, Italy Histiocytic syndromes represent a large, heterogeneous group of diseases resulting from proliferation of histiocytes. In addition to the classic variants, the subset of non-Langerhans cell histiocytoses comprises rare entities that have more recently been described. These last include both forms that affect only the skin or the skin and mucous membranes, and usually show a benign clinical behavior, and forms involving also internal organs, which may follow an aggressive course. The goal of this review is to outline the clinical, histologic, and ultrastructural features and the course, prognosis, and management of these unusual histiocytic syndromes. ( J Am Acad Dermatol 2007;57:1031-45.) istiocytic syndromes represent a large, puzzling group of diseases resulting from Abbreviations used: proliferation of cells called histiocytes.1 BCH: benign cephalic histiocytosis H ECD: Erdheim-Chester disease The term ‘‘histiocyte’’ includes cells of both the GEH: generalized eruptive histiocytosis monocyte-macrophage series and the Langerhans HPMH: hereditary progressive mucinous cell (LC) series, both antigen-processing and anti- histiocytosis 1 IC: indeterminate cell gen-presenting cells deriving from CD34 progeni- ICH: indeterminate cell histiocytosis tor cells in the bone marrow. JXG: juvenile xanthogranuloma In 1987, the Histiocyte Society proposed a classi- LC: Langerhans cell LCH: Langerhans cell histiocytoses fication of histiocytic syndromes based on 3 classes: MR: multicentric reticulohistiocytosis (1) class I, corresponding to LC histiocytoses (LCH); PNH: progressive nodular histiocytosis (2) class II, encompassing the histiocytoses of mon- PX: papular xanthoma onuclear phagocytes other than LC (non-LCH); and SBH: sea-blue histiocyte 2 SBHS: sea-blue histiocytic syndrome (3) class III, comprising the malignant histiocytoses. -
Revista2vol87ingle Snaza Layout 1
324 SYNDROME IN QUESTION ▲ Do you know this syndrome? * Você conhece esta síndrome? Aristóteles Rosmaninho 1 Teresa Pinto-Almeida 2 Iolanda Conde Fernandes 3 Susana Machado 4 Manuela Selores 5 CASE REPORT A 65 year-old man presented for evaluation of lesions were observed in his two brothers and father. multiple widespread nodules in his body. The lesions Some lesions were surgically excised because they were long standing and began during his childhood. caused functional discomfort. The histopathological More lesions appeared over time. On physical exami- examination showed the presence of globules of nation multiple, subcutaneous, soft, mobile and non mature white adipose tissue surrounded by thin painful nodules and tumors were observed in the fibrous capsules. The analytical study showed no sig- arms, legs and abdomen distorting the affected areas nificant abnormalities including lipid abnormalities. (Figures 1, 2 and 3). His past medical history was Based on the characteristic clinical history, family his- remarkable for diabetes mellitus and hepatocarcino- tory and histopathology the diagnosis of familial mul- ma secondary to chronic HBV infection. He denied tiple lipomatosis (FML) was made. alcohol consumption. Similar but less extensive A B C FIGURE 1: Multiple subcutaneous lesions in the abdomen FIGURE 2: Multiple subcutaneous lesions in the arms A B C FIGURE 3: Subcutaneous lesions in the legs Received on 03.08.2011. Approved by the Advisory Board and accepted for publication on 22.11.2011. * Work carried out at the Centro Hospitalar do Porto-Hospital de Santo António (EPE-HSA) - Porto, Portugal. Conflict of interest: None / Conflito de interesse: Nenhum Financial funding: None / Suporte financeiro: Nenhum 1 Intern in Dermatovenereology - Centro Hospitalar do Porto-Hospital de Santo António (EPE-HSA) - Porto, Portugal. -
Xanthoma Disseminatum: Case Report and Mini-Review of the Literature
View metadata, citation and similar papers at core.ac.uk brought to you by CORE Acta Dermatovenerol Croat 2014;22(2):150-154 CASE REPORT Xanthoma Disseminatum: Case Report and Mini-Review of the Literature Michael Park1, Barbara Boone2, Steven Devos1 1Clinic: BVBA Dermatoloog Dr. Devos Oostende; 2Clinic: Ghent University Hospital Corresponding author: SUMMARY Xanthoma disseminatum is a non-familial disorder of non-Langerhans cell ori- Michael Park, MD gin or a class II histiocytosis with unknown etiology, with just over 100 cases reported in the literature. Because of the rarity of this disease, there is no established treatment. We Karel Janssenslaan 41 studied clinical manifestations and different treatments of xanthoma disseminatum from 8400 Oostende a series of cases, including our own patient. Belgium We studied 15 articles on treatment of xanthoma disseminatum. Local treatment with [email protected] cryotherapy, radiotherapy, surgery, and carbon dioxide lasers have been attempted with various results. Systemic medication with peroxisome proliferator-activated gamma recep- tors, statins, fenofibrate, chlorodeoxyadenosine, cyclophosphamide, doxycycline, and cy- Received: April 29, 2013 closporine have also been reported, but none have proven particularly successful. Accepted: January 15, 2014 Xanthoma disseminatum is usually benign and is often self-limiting. If the lesions are accessible to surgery, that is likely to give the best results. However, if the lesions are not accessible for surgical removal then carbon dioxide laser treatment may be considered. The choice of oral treatment should be made on the basis of the patient’s condition, since none of them have proven particularly effective. Expectant management is justifiable as long as the lesions are limited to the skin. -
Sequence Diversity in Genes of Lipid Metabolism Christine Kim Garcia,1 Gabriele Mues,2 Yuanlan Liao,1 Tommy Hyatt,1 Nila Patil,3 Jonathan C
Downloaded from genome.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press Letter Sequence Diversity in Genes of Lipid Metabolism Christine Kim Garcia,1 Gabriele Mues,2 Yuanlan Liao,1 Tommy Hyatt,1 Nila Patil,3 Jonathan C. Cohen,1 andHelen H. Hobbs 1,4 Departments of 1Internal Medicine and Molecular Genetics and 2Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9046, USA; 3Affymetrix, Inc., Santa Clara, California 95051, USA Elevated plasma lipoprotein levels play a crucial role in the development of coronary artery disease. Genetic factors strongly influence the levels of plasma lipoproteins, but the genes and sequence variations contributing to the most common forms of dyslipidemias are not known. We used GeneChip probe arrays to resequence the coding regions of 10 key genes of lipid metabolism. The sequences of these genes were analyzed in 80 dyslipidemic individuals. Fourteen nonsynonymous and twenty-two synonymous single nucleotide changes were identified that could be confirmed by conventional sequencing. Seven of the fourteen nonsynonymous sequence variants were polymorphisms with allele frequency >1% in the general population. The remaining seven were not found in normolipidemic controls (25 Caucasians and 25 African-Americans). The relationship between nonsynonymous sequence variations and various dyslipidemias was explored in association and family studies. No evidence was found for coding sequence variations in any of the 10 genes contributing to dyslipidemia. Only a single sequence variation, a missense mutation in the low density lipoprotein receptor gene, co-segregated with hyperlipidemia in the proband’s family. This study illustrates some of the difficulties associated with identifying sequence variations contributing to complex traits. -
A Case of Symmetrical Lipomatosis of the Tongue Presenting As Macroglossia
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Oral Science International, November 2006, p.90-93 Copyright © 2006, Japanese Stomatology Society. All Rights Reserved. A Case of Symmetrical Lipomatosis of the Tongue Presenting as Macroglossia Yoshimi Ishikawa, Yu Katada, Masahiro Enomoto, Kensuke Kawada, Yoshiyuki Okamoto and Mikio Ozawa Department of Oral Surgery, Fujisawa City Hospital (Chief: Dr. Yoshimi Ishikawa) Abstract: Symmetrical lipomatosis is characterized by symmetrical infi ltration of adipose tissue into the head, neck, or upper trunk. By contrast, oral involvement is extremely rare. The present report describes a case of symmetrical lipomatosis of the tongue (SLT) presenting as macroglossia. The patient was a 63-year- old Japanese male who developed progressive dysarthria secondary to enlargement of the tongue. The pa- tient's medical history was notable for alcoholic hepatitis and hyperlipidemia. Marginal glossectomy was per- formed on both sides of the tongue to achieve volume reduction and restore normal speech. Histopathologic examination of the resected tissue revealed diffuse infi ltration with adipose tissue lacking a fi brous capsule. The patient's postoperative course was uneventful, and he remained free of recurrence or regrowth and func- tional defi cits at the 6-year follow-up time point. Key words: Symmetrical lipomatosis, Macroglossia, Dysarthria, Alcoholic hepatitis, Hyperlipidemia Introduction thria since developing painless swelling of the tongue Benign symmetrical lipomatosis (BSL) is character- border in 1993 was referred to our clinic on August 4, ized by symmetrical infi ltrating growth of non-encapsu- 1996. The patient was 165 cm tall and weighed 53 kg lated mature adipose tissue. -
A Case of Generalized Eruptive Histiocytosis
Acta Derm Venereol 2007; 87: 533–536 CLINICAL REPORT A Case of Generalized Eruptive Histiocytosis Beatriz FERNÁNDEZ-JORGE1, Jaime GODAY-BUJÁN1, Jesús DEL POZO LOSADA1, Roberto ÁlvaREZ-RODRÍGUEZ2 and Eduardo FONSECA Departments of 1Dermatology and 2Pathology, Hospital Juan Canalejo, A Coruña, Spain Histiocytoses are a heterogeneous group of diseases, proliferation of benign histiocytes without deposition of characterized by the accumulation of reactive or neo lipids, iron or mucine. Electron microscopy reveals that plastic histiocytes in various tissues. Generalized erup these cells may possess various markers, such as comma- tive histiocytosis belongs to cutaneous nonLangerhans’ shaped bodies, dense bodies and regularly laminated cell histiocytoses and is a rare, generalized, selfhealing bodies, but no Birbeck granules. Herein we report a case disorder that usually follows a benign clinical course. of GEH in a 41-year-old woman with peculiar clinical Herein, we report a case of generalized eruptive histio and immunohistochemical features. cytosis in a 41yearold woman with peculiar clinical and histological features. Clinically, the papules showed a marked distribution into the seborrhoeic areas of the Case REPORT trunk, with a great tendency to coalesce. Furthermore, A 41-year-old woman presented with a 3-month history immunohistochemical labelling demonstrated that the of progressive appearance of brown to reddish and histiocytes were positive for CD68, but negative for slightly elevated macules and papules, symmetrically CD34, S100, CD1a and XIIIa factor. This is the second distributed on the seborrhoeic areas of the trunk and report of generalized eruptive histiocytosis with a nega extensor surface of both upper arms (Figs 1 and 2). -
Case Report Xanthoma Disseminatum: Report of One Case
Int J Clin Exp Pathol 2019;12(12):4349-4353 www.ijcep.com /ISSN:1936-2625/IJCEP0103968 Case Report Xanthoma disseminatum: report of one case Wei Kong1, Zhichao Liu1, Shupeng Zhang2 Departments of 1Dermatology, 2Pathology, Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, China Received October 24, 2019; Accepted November 26, 2019; Epub December 1, 2019; Published December 15, 2019 Abstract: An 8-year-old female had generalized papules and nodules for more than 6 years. Urine routine, blood lipid level, and cranial CT were normal. Histopathology of the lesion revealed that it consisted of abundant short spindle-shaped and epithelioid cell proliferation with foam cells and Touton giant cells. On immunohistochemistry, cells were CD68, CD31, and Ki-67<3% positive but were non-reactive to CK-pan, CD1a, and S-100. Diagnosis: xan- thoma disseminatum. Keywords: Xanthoma disseminatum, differential diagnosis, treatment Introduction a high fat diet. None of the family members had hyperlipidemia. Xanthoma disseminatum (XD) is currently con- sidered to be a rare benign manifestation of Physical examination: no obvious abnormality non-Langerhans cell histiocytosis (NLCH). It is was found in the system examination. reported that the population infected with XD is Dermatological examination: papules and nod- between 5 months and 70 years old, most of ules of different sizes distributed on the trunk whom are younger than 25 years old [1]. The and limbs, with a diameter of about 0.5-1.3 cm main manifestation is the yellow-brown papule which were higher than the skin surface. nodules that are symmetrically distributed on Multiple yellowish-brown papules and nodules the face, trunk, and limb folds.